Stocks and Investing
Stocks and Investing
Mon, January 24, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Edward White Maintained (TGTX) at Strong Buy with Decreased Target to $70 on, Jan 24th, 2022
Edward White of HC Wainwright & Co., Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Decreased Target from $75 to $70 on, Jan 24th, 2022.
Edward has made no other calls on TGTX in the last 4 months.
There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 0 agree with Edward's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Edward
- Graig Suvannavejh of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $13 on, Wednesday, December 1st, 2021
- Joshua Schimmer of "Evercore ISI Group" Maintained at Buy with Decreased Target to $36 on, Wednesday, December 1st, 2021
Contributing Sources